Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): Rationale and design

EuroIntervention

Volumn 7, Issue 12, 2012, Pages 1435-1443

  Räber, Lorenz ^a   Kelbaek, Henning ^b   Ostoijc, Miodrag ^c   Baumbach, Andreas ^d   Tüller, David ^e   Von Birgelen, Clemens ^f   Roffi, Marco ^g   Pedrazzini, Giovanni ^h   Kornowski, Ran ^i,m   Weber, Klaus ^j   Heg, Dik ^k   Matter, Christian ^l   Lüscher, Thomas ^l   Taniwaki, Masanori ^a   Meier, Bernhard ^a   Jüni, Peter ^k   Windecker, Stephan ^a,k  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Rigshospitalet   (Denmark)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e Cardiology Department   (Switzerland)

^f UNIVERSITY OF TWENTE   (Netherlands)

^g REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^h UNIVERSITY HOSPITAL   (Switzerland)

ⁱ RABIN MEDICAL CENTER   (Israel)

^j Herzzentrum Bodensee ^*  (Switzerland)

^k UNIVERSITY OF BERN   (Switzerland)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^m TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

Bare metal stent; Biolimus eluting stent; Drug eluting stent with erodible polymer; Randomised controlled trial; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; PRASUGREL; UMIROLIMUS;

ACUTE DISEASE; ARTICLE; BARE METAL STENT; BIODEGRADABILITY; BLEEDING; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG TOLERABILITY; EQUIPMENT DESIGN; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAINTENANCE THERAPY; MATERIAL COATING; OUTCOME ASSESSMENT; POLYMERIZATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS;

DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; HUMANS; METALS; MYOCARDIAL INFARCTION; POLYMERS; RESEARCH DESIGN; SIROLIMUS;

EID: 84860198947     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I12A224     Document Type: Article

References (33)

1. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga Jz, Brodie Br, Dudek D, Mockel M, Ochala A, Kellock A, Parise H, Mehran R. Paclitaxel-Eluting Stents Versus Bare-Metal Stents In Acute Myocardial Infarction. N Engl J Med. 2009;360:1946-1959.
2. Spaulding C, Daemen J, Boersma E, Cutlip D, Serruys PW. A Pooled Analysis Of Data Comparing Sirolimus-Eluting Stents With Bare-Metal Stents. N Engl J Med. 2007;356:989-997. (Pubitemid 46376799)
3. Laarman GJ, Suttorp MJ, Dirksen MT, Van Heerebeek L, Kiemeneij F, Slagboom T, Van Der Wieken LR, Tijssen JG, Rensing BJ, Patterson M. Paclitaxel-Eluting Versus Uncoated Stents In Primary Percutaneous Coronary Intervention. N Engl J Med. 2006;355:1105-1113. (Pubitemid 44394917)
4. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, Giulivi A, Alborino D, Azzellino A, Violini R. Randomized Trial Of Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction (Sesami). J Am Coll Cardiol. 2007;49:1924-1930. (Pubitemid 46694284)
5. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R. Tirofiban And Sirolimus-Eluting Stent Vs Abciximab And Bare-Metal Stent For Acute Myocardial Infarction: A Randomized Trial. JAMA. 2005;293:2109-2117. (Pubitemid 40617063)
6. Valgimigli M, Campo G, Percoco G, Bolognese L, Vassanelli C, Colangelo S, De Cesare N, Rodriguez AE, Ferrario M, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro Ms, Parrinello G, Ferrari R. Comparison Of Angioplasty With Infusion Of Tirofiban Or Abciximab And With Implantation Of Sirolimus-Eluting Or Uncoated Stents For Acute Myocardial Infarction: The Multistrategy Randomized Trial. JAMA. 2008;299:1788-1799. (Pubitemid 351549970)
7. Van Der Hoeven BL, Liem SS, Dijkstra J, Bergheanu SC, Putter H, Antoni ML, Atsma DE, Bootsma M, Zeppenfeld K, Jukema JW, Schalij MJ. Stent Malapposition After Sirolimus-Eluting And Bare-Metal Stent Implantation In Patients With St-Segment Elevation Myocardial Infarction: Acute And 9-Month Intravascular Ultrasound Results Of The Mission! Intervention Study. JACC Cardiovasc Interv. 2008;1:192-201. (Pubitemid 351506561)
8. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G. Use Of Drug-Eluting Stents In Acute Myocardial Infarction: A Systematic Review And Meta-Analysis. J Am Coll Cardiol. 2009;53:1677-1689.
9. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed Arterial Healing And Increased Late Stent Thrombosis At Culprit Sites After Drug-Eluting Stent Placement For Acute Myocardial Infarction Patients: An Autopsy Study. Circulation. 2008;118: 1138-1145.
10. Räber L. Differential Healing Response In Acute Coronary Syndrome Versus Stable Coronary Artery Disease Patients 5 Years Following Early Generation Des Implantation: An Optical Coherence Tomography Study. Presented At The Transcatheter Cardiovascular Therapeutics Meeting, San Francisco, C.A., November 8, September 2011.
11. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E. Incomplete Stent Apposition And Delayed Tissue Coverage Are More Frequent In Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention For St-Segment Elevation Myocardial Infarction Than In Drug-Eluting Stents Implanted For Stable/Unstable Angina: Insights From Optical Coherence Tomography. JACC Cardiovasc Interv. 2009;2:445-452.
12. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete Stent Apposition And Very Late Stent Thrombosis After Drug-Eluting Stent Implantation. Circulation. 2007;115:2426-2434. (Pubitemid 46717965)
13. Cook S, Eshtehardi P, Kalesan B, Räber L, Wenaweser P, Togni M, Moschovitis A, Vogel R, Seiler C, Eberli F, Lüscher T, Meier B, Juni P, Windecker S. Impact Of Incomplete Stent Apposition On Long-Term Clincal Outcome After Drug-Eluting Stent Implantation. Eur Heart J. 2012 Jan 26. [Epub ahead of print]
14. Van Der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, Van Der Wall EE, Schalij MJ. Sirolimus-Eluting Stents Versus Bare-Metal Stents In Patients With St-Segment Elevation Myocardial Infarction: 9-Month Angiographic And Intravascular Ultrasound Results And 12-Month Clinical Outcome Results From The Mission! Intervention Study. J Am Coll Cardiol. 2008;51:618-626. (Pubitemid 351186867)
15. Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA, Jr., Dressler O, Parise H, Mehran R, Stone GW. Incidence, Mechanisms, Predictors, And Clinical Impact Of Acute And Late Stent Malapposition After Primary Intervention In Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy Of The Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction (Horizons-Ami) Trial. Circulation. 2010;122:1077-1084.
16. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, Matiashvili A, Lortkipanidze N, Mihalcsik L, Trivisonno A, Valsecchi O, Mintz GS, Dressler O, Parise H, Maehara A, Cristea E, Lansky AJ, Mehran R, Stone GW. Strut Coverage And Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents In Acute Myocardial Infarction: Optical Coherence Tomography Substudy Of The Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction (Horizons-Ami) Trial. Circulation. 2011;123:274-281.
17. Kalesan B, Pilgrim T, Heinimann K, Räber L, Stefanini GG, Valgimigli M, Da Costa B, Mach F, Luscher TF, Windecker S, Jüni P. Comparison Of Drug-Eluting Stents With Bare Metal Stents In Patients With St-Segment Elevation Myocardial Infarction. Eur Heart J. 2012; In Press.
18. Finn AV, Nakazawa G, Kolodgie F, Virmani R. Drug Eluting Or Bare Metal Stent For Acute Myocardial Infarction: An Issue Of Safety? Eur Heart J. 2009;30:1828-1830.
19. Raber L, Windecker S. Current Status Of Drug-Eluting Stents. Cardiovasc Ther. 2011;29:176-189.
20. Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, Den Heijer P, Bethencourt A, Vazquez N, Brugaletta S, Backx B, Serruys P. Rationale And Design Of The Examination Trial: A Randomised Comparison Between Everolimus-Eluting Stents And Cobalt-Chromium Bare-Metal Stents In St-Elevation Myocardial Infarction. EuroIntervention. 2011;7:977-984.
21. Grube E, Buellesfeld L. Biomatrix Biolimus A9-Eluting Coronary Stent: A Next-Generation Drug-Eluting Stent For Coronary Artery Disease. Expert Rev Med Devices. 2006;3: 731-741. (Pubitemid 46017613)
22. Grube E, Hauptmann KE, Buellesfeld L, Lim V, Abizaid A. Six-Month Results Of A Randomized Study To Evaluate Safety And Efficacy Of A Biolimus A9 Eluting Stent With A Biodegradable Polymer Coating. EuroIntervention. 2005;1:53-57.
23. Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Van Es GA, Meier B, Windecker S, Juni P. Long-Term Clinical Outcomes Of Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents In Patients With Coronary Artery Disease (Leaders): 4 Year Follow-Up Of A Randomised Non-Inferiority Trial. Lancet. 2011;378:1940-1948.
24. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, Coleman L, Wong GK, Edelman ER. Stent Thrombogenicity Early In High-Risk Interventional Settings Is Driven By Stent Design And Deployment And Protected By Polymer-Drug Coatings. Circulation. 2011;123:1400-1409.
25. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive Manual Thrombectomy Improves Myocardial Perfusion And Mortality In Patients Undergoing Primary Percutaneous Coronary Intervention For St-Elevation Myocardial Infarction: A Meta-Analysis Of Randomized Trials. Eur Heart J. 2008;29:3002-3010.
26. Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S. Double-Dose Versus Standard-Dose Clopidogrel And High-Dose Versus Low-Dose Aspirin In Individuals Undergoing Percutaneous Coronary Intervention For Acute Coronary Syndromes (Current-Oasis 7): A Randomised Factorial Trial. Lancet. 2010;376:1233-1243.
27. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, Mccabe CH, Antman EM. Prasugrel Compared With Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention For St-Elevation Myocardial Infarction (Triton-Timi 38): Double-Blind, Randomised Controlled Trial. Lancet. 2009;373:723-731.
28. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA. Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes. N Engl J Med. 2009;361:1045-57.
29. Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW. Myocardial Infarction Adjudication In Contemporary All-Comer Stent Trials: Balancing Sensitivity And Specificity. Addendum To The Historical MI Definitions Used In Stent Studies. EuroIntervention. 2010;5:871-874.
30. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen Dj, Van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, Mcfadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical End Points In Coronary Stent Trials: A Case For Standardized Definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
31. Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E. Evaluation Of Prasugrel Compared With Clopidogrel In Patients With Acute Coronary Syndromes: Design And Rationale For The Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel Thrombolysis In Myocardial Infarction 38 (Triton-Timi 38). Am Heart J. 2006;152:627-635. (Pubitemid 44396884)
32. Investigators Tg. An International Randomized Trial Comparing Four Thrombolytic Strategies For Acute Myocardial Infarction. The Gusto Investigators. N Engl J Med. 1993;329: 673-682.
33. Mehran R, Rao SV, Bhatt DL, Gibson Cm, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized Bleeding Definitions For Cardiovascular Clinical Trials: A Consensus Report From The Bleeding Academic Research Consortium. Circulation. 2011;123:2736-2747.